Answers are grounded in this paper and cite their sources.
Correct inhalation technique is essential for the effective management of obstructive airway diseases. Guidelines recommend assessing inhalation technique and patient adherence at every visit. However, despite multiple available assessment methods, no single approach is currently recommended. The aim of the study was to compare three methods for assessing inhalation technique in patients with asthma and COPD: a checklist of inhalation errors, a 4-level inhalation technique rating scale, and assessment using the Vitalograph® AIM. In this prospective, single-center cohort study, 121 patients with asthma or COPD who used at least one inhaler regularly were enrolled. Inhalation technique was assessed simultaneously using the three methods by two independent observers. The reference assessment was performed by two experienced pulmonologists. Methods were compared in terms of reliability, validity, and utility. For the error checklist and the 4-level scale, interobserver agreement between the two investigators was moderate to good. The agreement was higher for dry powder inhalers (DPIs) (Cohen’s Kappa 0.663–0.732) than for metered-dose inhalers (MDIs) (Cohen’s Kappa 0.442–0.771). Among DPI users, reproducibility was good to very good for both observers and both methods (Cohen’s kappa 0.722 – 0.832); among MDI users, repeatability remained good (Cohen’s kappa 0.640 do 0.663), but lower than for DPIs. The agreement between observers and the expert reference assessment was good to very good at both visits (ICC 0.708 –0.863) In contrast, agreement among the three assessment methods was low, irrespective of investigator or inhaler type (ICC 0.216–0.303). Overall, the 4-level scale was rated as the easiest and least time-consuming method. In conclusion, the inhalation-error checklist and the 4-level scale are simple and practical methods for assessing inhalation technique. Assessment with the Vitalograph® AIM provides a more objective evaluation but is more complex and time-consuming. Given the low concordance among the three methods, they should not be used interchangeably. Trial registration: This study was registered at ClinicalTrials.gov (NCT04349735) on 16 December 2019.
No takes yet. Share an insight, caveat, or question.
Miszczuk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: